Eugene A Larson

Insider

First SEC filing: Nov. 25, 2003 · Latest: Nov. 25, 2003

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

3 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 13, 2005	INO	A	10,000	$3.34	$33,400	10,000 Direct	—	Acquired	-99.2% (price as of 2026-08-19)
Sept. 14, 2004	INO	P	1,544	$8.80	$13,587	1,544 Direct	—	Acquired	-99.7% (price as of 2026-08-19)
Sept. 14, 2004	INO	P	3	$17647.06	$52,941	3 Direct	—	Acquired	-100.0% (price as of 2026-08-19)
Aug. 6, 2004	INO	A	20,000	$0.93	$18,600	20,000 Direct	—	Acquired	-99.3% (price as of 2026-08-19)
June 17, 2004	INO	A	35,000	$1.33	$46,550	35,000 Direct	—	Acquired	-99.5% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 13, 2005	INO	Inovio Biomedical Corporation Common Stock	Inovio Biomedical Corporation Common Stock (10,000)	$3.34	May 12, 2015	10,000	Acquired
Sept. 14, 2004	INO	Genetronics Biomedical Corp Common Stock Warrants	Genetronics Biomedical Corporation Common Stock	$8.80	May 10, 2009	1,544	Acquired
Aug. 6, 2004	INO	Common Stock	Common Stock (20,000)	$0.93	Aug. 5, 2014	20,000	Acquired
June 17, 2004	INO	Common Stock	Common Stock (35,000)	$1.33	June 16, 2014	35,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Nov. 25, 2003	INO	Common Stock→ Common Stock (50,000)	50,000	Direct